nonprofit logo

Hemophilia Services Consortium Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 133875950 ✦ New york, NY ✦ Designated as a 501(c)(3)

Overview

What is Hemophilia Services Consortium Inc?

The Hemophilia Services Consortium Inc, located in New York City, is a nonprofit organization dedicated to enhancing accessible and affordable care for individuals with hemophilia and other bleeding disorders in the New York metropolitan area. They ensure a reliable supply of blood-clotting concentrates and other essential medications by purchasing and dispensing these treatments cooperatively and on a centralized basis to their patron hospitals. Besides, they offer additional services permitted for tax-exempt corporations under sections 501(e) and 501(c)(3) of the Code.


Is Hemophilia Services Consortium Inc legitimate?

Hemophilia Services Consortium Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Hemophilia Services Consortium Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


What is the mission statement of Hemophilia Services Consortium Inc?
What is the revenue of Hemophilia Services Consortium Inc?
Who are the executives of Hemophilia Services Consortium Inc and what are their salaries?
Where can I find the form 990 for Hemophilia Services Consortium Inc?

Mission Statement of Hemophilia Services Consortium Inc

The Hemophilia Services Consortium Inc is a non-profit organization dedicated to enhancing affordable care for individuals with bleeding disorders in the New York metropolitan area. Through its mission, the consortium aims to ensure an available supply of blood-clotting concentrates and other medications for the treatment of hemophilia and other blood-clotting disorders.

In practice, Hemophilia Services Consortium Inc functions by purchasing and dispensing these essential medications to its patron hospitals on a cooperative, centralized basis. By doing so, the consortium helps to make these life-saving treatments more accessible and affordable for those who need them. In addition to its medication distribution services, the organization provides other permissible services for corporations exempt from taxation under sections 501(e) and 501(c)(3) of the tax code.

The Hemophilia Services Consortium Inc plays a vital role in the healthcare community by addressing the unique needs of individuals with bleeding disorders. By centralizing the purchasing and distribution of necessary medications, the consortium enables hospitals to focus on providing high-quality care to their patients. Furthermore, the organization's mission aligns with the broader goal of improving the overall health and well-being of the community by ensuring that essential treatments are readily available to those who need them.

In summary, the Hemophilia Services Consortium Inc is a compassionate and essential organization that enhances affordable care for individuals with bleeding disorders in the New York metropolitan area. Through its mission to supply blood-clotting concentrates and other medications for the treatment of hemophilia and other blood-clotting disorders, the consortium helps to ensure that these vital treatments are accessible to those who need them most.

Impact

This information is meant to be a general summary of Hemophilia Services Consortium Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




Thursday, August 15, 2024

Hemophilia Services Consortium Inc plays a crucial role in enhancing affordable care for individuals with hemophilia and other bleeding disorders in the New York metropolitan area. By ensuring an available supply of blood-clotting concentrates and other necessary medications through centralized purchasing and dispensing to patron hospitals, the organization directly impacts the accessibility and quality of treatment for those in need. This proactive approach not only aids in managing the symptoms of hemophilia and related conditions but also contributes to improving the overall well-being and quality of life for affected individuals in the region.





Financials

This financial information is from Propublica.

Revenue
Expenses
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $2,908
  • Program Service Revenue: $20,390,179
  • Gross Receipts: $20,563,934

    • Assets and Liabilities:
  • Total Assets: $5,868,302
  • Total Liabilities: $5,743,891
  • Net Assets: $124,411
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    BLOOD FACTOR - HSC

    Revenue

    $12,594,696

    BLOOD FACTOR - AGENT

    Revenue

    $7,795,483

    Organization Details

    Founding Year

    1997

    Main Address

    525 EAST 68TH STREET BOX 156, NEW YORK, NY, 10065

    NTEE Category

    Code: E21Z - Health

    If you are a representative of Hemophilia Services Consortium Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.